China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The efficacy and safety of Desvenlafaxine Succinate Sustained-release Tablets in the prophylactic treatment of migraine'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130113
Registration Time: 2026/08/14
Type: Interventional study
Primary Sponsor: the Second Affiliated Hospital of Soochow University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334175
Published by HT Digital Content Services with permission from Health Daily Digest....